524 related articles for article (PubMed ID: 29626453)
21. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
[TBL] [Abstract][Full Text] [Related]
22. Model for End-stage Liver Disease excluding INR (MELD-XI) score in critically ill patients: Easily available and of prognostic relevance.
Wernly B; Lichtenauer M; Franz M; Kabisch B; Muessig J; Masyuk M; Hoppe UC; Kelm M; Jung C
PLoS One; 2017; 12(2):e0170987. PubMed ID: 28151948
[TBL] [Abstract][Full Text] [Related]
23. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score.
Thomas SS; Nahumi N; Han J; Lippel M; Colombo P; Yuzefpolskaya M; Takayama H; Naka Y; Uriel N; Jorde UP
J Heart Lung Transplant; 2014 Jul; 33(7):675-81. PubMed ID: 24726424
[TBL] [Abstract][Full Text] [Related]
24. Model for end-stage liver disease excluding international normalized ratio (MELD-XI) score predicts heart transplant outcomes: Evidence from the registry of the United Network for Organ Sharing.
Deo SV; Al-Kindi SG; Altarabsheh SE; Hang D; Kumar S; Ginwalla MB; ElAmm CA; Sareyyupoglu B; Medalion B; Oliveira GH; Park SJ
J Heart Lung Transplant; 2016 Feb; 35(2):222-7. PubMed ID: 26527533
[TBL] [Abstract][Full Text] [Related]
25. Predicting outcomes following short-term ventricular assist device implant with the MELD-XI score.
Pidborochynski T; Bozso SJ; Buchholz H; Freed DH; MacArthur R; Conway J
Artif Organs; 2023 Nov; 47(11):1752-1761. PubMed ID: 37476924
[TBL] [Abstract][Full Text] [Related]
26. End-Stage Liver Disease Models and Outcomes in Pediatric Patients Supported With Short-Term Continuous-Flow Ventricular Assist Devices.
Malik G; Pidborochynski T; Buchholz H; Freed DH; Al-Aklabi M; Bozso SJ; Choudhry S; Anand V; Holinski P; Conway J
ASAIO J; 2020 Aug; 66(8):933-938. PubMed ID: 32740355
[TBL] [Abstract][Full Text] [Related]
27. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
[TBL] [Abstract][Full Text] [Related]
28. Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation.
Borgi J; Tsiouris A; Hodari A; Cogan CM; Paone G; Morgan JA
Ann Thorac Surg; 2013 Jan; 95(1):163-9. PubMed ID: 23103012
[TBL] [Abstract][Full Text] [Related]
29. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation.
Topilsky Y; Oh JK; Shah DK; Boilson BA; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
JACC Cardiovasc Imaging; 2011 Mar; 4(3):211-22. PubMed ID: 21414567
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of the modified model for end-stage liver disease (MELD) score including albumin in acute heart failure.
Liao S; Lu X; Cheang I; Zhu X; Yin T; Yao W; Zhang H; Li X
BMC Cardiovasc Disord; 2021 Mar; 21(1):128. PubMed ID: 33750318
[TBL] [Abstract][Full Text] [Related]
31. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction.
Kim MS; Kato TS; Farr M; Wu C; Givens RC; Collado E; Mancini DM; Schulze PC
J Am Coll Cardiol; 2013 Jun; 61(22):2253-2261. PubMed ID: 23563127
[TBL] [Abstract][Full Text] [Related]
32. Durable Biventricular Support Using Right Atrial Placement of the HeartWare HVAD.
Tran HA; Pollema TL; Silva Enciso J; Greenberg BH; Barnard DD; Adler ED; Pretorius VG
ASAIO J; 2018; 64(3):323-327. PubMed ID: 28841580
[TBL] [Abstract][Full Text] [Related]
33. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
34. Preoperative Pectoralis Muscle Quantity and Attenuation by Computed Tomography Are Novel and Powerful Predictors of Mortality After Left Ventricular Assist Device Implantation.
Teigen LM; John R; Kuchnia AJ; Nagel EM; Earthman CP; Kealhofer J; Martin C; Cogswell R
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912261
[TBL] [Abstract][Full Text] [Related]
35. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
36. Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices.
Anjum A; Kurihara C; Critsinelis A; Kawabori M; Sugiura T; Civitello AB; Etheridge WB; Delgado RM; Simpson L; George JK; Nair AP; Frazier OH; Morgan JA
J Artif Organs; 2018 Sep; 21(3):285-292. PubMed ID: 29766321
[TBL] [Abstract][Full Text] [Related]
37. Red Cell Distribution Width Predicts 90 Day Mortality in Continuous-Flow Left Ventricular Assist Device Patients.
Truby LK; Sridharan L; Flores RJ; Garan AR; Jennings D; Yuzefpolskaya M; Takeda K; Takayama H; Naka Y; Colombo PC; Topkara VK
ASAIO J; 2019; 65(3):233-240. PubMed ID: 29734258
[TBL] [Abstract][Full Text] [Related]
38. Pre-Operative Right Ventricular Dysfunction Is Associated With Gastrointestinal Bleeding in Patients Supported With Continuous-Flow Left Ventricular Assist Devices.
Sparrow CT; Nassif ME; Raymer DS; Novak E; LaRue SJ; Schilling JD
JACC Heart Fail; 2015 Dec; 3(12):956-64. PubMed ID: 26577618
[TBL] [Abstract][Full Text] [Related]
39. Changes in renal function after implantation of continuous-flow left ventricular assist devices.
Hasin T; Topilsky Y; Schirger JA; Li Z; Zhao Y; Boilson BA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Joyce L; Daly R; Park SJ; Kushwaha SS
J Am Coll Cardiol; 2012 Jan; 59(1):26-36. PubMed ID: 22192665
[TBL] [Abstract][Full Text] [Related]
40. De novo aortic regurgitation after continuous-flow left ventricular assist device implantation.
Patil NP; Sabashnikov A; Mohite PN; Garcia D; Weymann A; Zych B; Bowles CT; Hards R; Hedger M; Popov AF; De Robertis F; Moza A; Bahrami T; Amrani M; Rahman-Haley S; Banner NR; Simon AR
Ann Thorac Surg; 2014 Sep; 98(3):850-7. PubMed ID: 25069685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
